Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis.
Siafis S, Çıray O, Schneider-Thoma J, Bighelli I, Krause M, Rodolico A, Ceraso A, Deste G, Huhn M, Fraguas D, Mavridis D, Charman T, Murphy DG, Parellada M, Arango C, Leucht S. Siafis S, et al. Among authors: parellada m. Mol Autism. 2020 Aug 26;11(1):66. doi: 10.1186/s13229-020-00372-z. Mol Autism. 2020. PMID: 32847616 Free PMC article.
Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials).
Crutel V, Lambert E, Penelaud PF, Albarrán Severo C, Fuentes J, Rosier A, Hervás A, Marret S, Oliveira G, Parellada M, Kyaga S, Gouttefangeas S, Bertrand M, Ravel D, Falissard B. Crutel V, et al. Among authors: parellada m. J Autism Dev Disord. 2021 Aug;51(8):2959-2972. doi: 10.1007/s10803-020-04709-8. J Autism Dev Disord. 2021. PMID: 33151500 Free PMC article. Clinical Trial.
Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials).
Crutel V, Lambert E, Penelaud PF, Albarrán Severo C, Fuentes J, Rosier A, Hervás A, Marret S, Oliveira G, Parellada M, Kyaga S, Gouttefangeas S, Bertrand M, Ravel D, Falissard B. Crutel V, et al. Among authors: parellada m. J Autism Dev Disord. 2021 Aug;51(8):2973. doi: 10.1007/s10803-020-04822-8. J Autism Dev Disord. 2021. PMID: 33423216 Free PMC article. No abstract available.
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.
Siafis S, Çıray O, Wu H, Schneider-Thoma J, Bighelli I, Krause M, Rodolico A, Ceraso A, Deste G, Huhn M, Fraguas D, San José Cáceres A, Mavridis D, Charman T, Murphy DG, Parellada M, Arango C, Leucht S. Siafis S, et al. Among authors: parellada m. Mol Autism. 2022 Mar 4;13(1):10. doi: 10.1186/s13229-022-00488-4. Mol Autism. 2022. PMID: 35246237 Free PMC article.
Prevalence and Correlates of the Concurrence of Autism Spectrum Disorder and Obsessive Compulsive Disorder in Children and Adolescents: A Systematic Review and Meta-Analysis.
Aymerich C, Pacho M, Catalan A, Yousaf N, Pérez-Rodríguez V, Hollocks MJ, Parellada M, Krebs G, Clark B, Salazar de Pablo G. Aymerich C, et al. Among authors: parellada m. Brain Sci. 2024 Apr 13;14(4):379. doi: 10.3390/brainsci14040379. Brain Sci. 2024. PMID: 38672028 Free PMC article. Review.
Autism spectrum disorder: does neuroimaging support the DSM-5 proposal for a symptom dyad? A systematic review of functional magnetic resonance imaging and diffusion tensor imaging studies.
Pina-Camacho L, Villero S, Fraguas D, Boada L, Janssen J, Navas-Sánchez FJ, Mayoral M, Llorente C, Arango C, Parellada M. Pina-Camacho L, et al. Among authors: parellada m. J Autism Dev Disord. 2012 Jul;42(7):1326-41. doi: 10.1007/s10803-011-1360-4. J Autism Dev Disord. 2012. PMID: 21932156 Review.
Polypharmacy with antidepressants in children and adolescents.
Díaz-Caneja CM, Espliego A, Parellada M, Arango C, Moreno C. Díaz-Caneja CM, et al. Among authors: parellada m. Int J Neuropsychopharmacol. 2014 Jul;17(7):1063-82. doi: 10.1017/S1461145712001265. Epub 2012 Nov 29. Int J Neuropsychopharmacol. 2014. PMID: 23190624 Free article. Review.
248 results